KeyCorp Issues Positive Forecast for Integer (NYSE:ITGR) Stock Price

Integer (NYSE:ITGR) had its price objective boosted by KeyCorp from $144.00 to $154.00 in a research note published on Friday,Benzinga reports. The firm currently has an overweight rating on the medical equipment provider’s stock.

Other equities research analysts have also issued research reports about the company. Wells Fargo & Company restated an “overweight” rating and set a $160.00 target price on shares of Integer in a research report on Tuesday, December 3rd. Bank of America raised their price objective on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Truist Financial boosted their target price on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Citigroup raised their price target on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. Finally, Benchmark upped their price objective on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, October 21st. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $146.56.

Integer Trading Down 0.3 %

Shares of ITGR stock opened at $142.79 on Friday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $4.79 billion, a P/E ratio of 44.07, a P/E/G ratio of 1.80 and a beta of 1.12. Integer has a twelve month low of $94.56 and a twelve month high of $144.22. The stock’s fifty day simple moving average is $136.92 and its 200 day simple moving average is $129.42.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. The company had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. Integer’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.27 earnings per share. As a group, sell-side analysts predict that Integer will post 5.33 EPS for the current fiscal year.

Institutional Trading of Integer

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Loomis Sayles & Co. L P increased its holdings in shares of Integer by 3.0% during the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after acquiring an additional 15,446 shares in the last quarter. Jane Street Group LLC grew its position in Integer by 23.3% during the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after purchasing an additional 28,572 shares during the last quarter. Verition Fund Management LLC raised its holdings in Integer by 17.4% in the third quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after buying an additional 515 shares during the last quarter. Versant Capital Management Inc lifted its stake in shares of Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after buying an additional 183 shares in the last quarter. Finally, Lord Abbett & CO. LLC grew its holdings in shares of Integer by 3.5% during the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock valued at $37,716,000 after buying an additional 9,754 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.